Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Latest filing published 02 Apr 2026 for Ionis Pharmaceuticals INC, €397k. Read the official filing
Filing timeline
BuySaleShannon L. Devers
Insider track record
Disclosed buys
0
Disclosed sells
2
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Shannon L. Devers: trading record in brief
Shannon L. Devers (senior executive) discloses dealings in Ionis Pharmaceuticals Inc to SEC (Form 4). In total, 9 filings cover trades dated from 15 January 2025 to 2 April 2026.
The open-market record consists of 2 sales worth €674k, with no purchase. The rest of the record consists of 7 option exercises. 2026 to date brings no purchases and 2 sales.
On 2 April 2026 came the latest disclosure, an open-market sale for €397k in Ionis Pharmaceuticals Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. Section 16 rules allow two business days to file each Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Shannon L. Devers
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations9 total
6,193 shares@ US$74.053563.8% of flowCommon StockSEC:0000874015-26-000160:0
3,510 shares@ US$37.580.0009% mcap50.0% of flowCommon StockSEC:0000874015-26-000135:0
3,977 shares@ US$81.34038.8% of flowCommon StockSEC:0000874015-26-000077:0
17,377 shares0Common StockSEC:0000874015-26-000064:0
25,545 shares@ US$56.7839.6% of flowCommon StockSEC:0000874015-26-000029:0
16,777 shares@ US$53.7748.5% of flowCommon StockSEC:0000874015-25-000285:0
6,000 shares@ US$48.5130.0% of flowCommon StockSEC:0000874015-25-000260:0
2,234 shares@ US$37.5812.4% of flowCommon StockSEC:0000874015-25-000217:0
12,295 shares0Common StockSEC:0000874015-25-000058:0
9 of 9 declarations
